Next Article in Journal
Exploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections
Previous Article in Journal
Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 17
Issue 10
10.3390/ph17101374
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceuticals 2017, 10(3), 60.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60

by
Juan M. Viveros-Paredes
1,
Rocio E. González-Castañeda
2,
Juerg Gertsch
3,
Veronica Chaparro-Huerta
4,
Rocio I. López-Roa
1,
Eduardo Vázquez-Valls
5,
Carlos Beas-Zarate
6,
Antoni Camins-Espuny
7,8 and
Mario E. Flores-Soto
1,2,*
1
Departamento de Farmacobiología CUCEI, Universidad de Guadalajara, Guadalajara 44430, Mexico
2
Laboratorio de Microscopía de Alta Resolución, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
3
Institute of Biochemistry and Molecular Medicine, NCCR Trans Cure, University of Bern, CH-3012 Bern, Switzerland
4
Laboratorio de Neurobiología Celular y Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Guadalajara 44421, Mexico
5
Laboratorio de Inmunodeficiencias y Retrovirus Humanos, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44421, Mexico
6
Laboratorio de Regeneración y Desarrollo Neural, Instituto de Neurobiología, Departamento de Biología Celular y Molecular, CUCBA, Universidad de Guadalajara, Guadalajara 44340, Mexico
7
Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia i Ciencias de l’Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
8
Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(10), 1374; https://doi.org/10.3390/ph17101374
Submission received: 5 April 2024 / Accepted: 8 October 2024 / Published: 16 October 2024
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 5 as published. We used the wrong image for “BCP” in Figure 5A. The corrected Figure 5 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Viveros-Paredes, J.M.; González-Castañeda, R.E.; Gertsch, J.; Chaparro-Huerta, V.; López-Roa, R.I.; Vázquez-Valls, E.; Beas-Zarate, C.; Camins-Espuny, A.; Flores-Soto, M.E. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60. [Google Scholar] [CrossRef] [PubMed]
Pharmaceuticals 17 01374 g005
Figure 5. BCP treatment attenuates MPTP-induced nigrostriatal dopaminergic neuronal damage. C57BL/6 mice were treated with MPTP for 5 days (30 mg/kg, i.p.). The mice were sacrificed on the 3rd day after MPTP injection after being subjected to behavioural tests. Photomicrographs of representative STR (A) sections stained with an antibody against TH. Reduced activity of TH-neurons was observed in the MPTP-treated mice, which was partially prevented by treatment with BCP. The number of TH-positive fibres in the STR (B) was expressed as the mean ± SEM of six individual experiments. *** p < 0.001, CTL vs. MPTP treatment. * p < 0.05, MPTP treatment vs. BCP + MPTP treatment. *** p < 0.001, CTL vs. AM630 + BCP + MPTP treatment.
Figure 5. BCP treatment attenuates MPTP-induced nigrostriatal dopaminergic neuronal damage. C57BL/6 mice were treated with MPTP for 5 days (30 mg/kg, i.p.). The mice were sacrificed on the 3rd day after MPTP injection after being subjected to behavioural tests. Photomicrographs of representative STR (A) sections stained with an antibody against TH. Reduced activity of TH-neurons was observed in the MPTP-treated mice, which was partially prevented by treatment with BCP. The number of TH-positive fibres in the STR (B) was expressed as the mean ± SEM of six individual experiments. *** p < 0.001, CTL vs. MPTP treatment. * p < 0.05, MPTP treatment vs. BCP + MPTP treatment. *** p < 0.001, CTL vs. AM630 + BCP + MPTP treatment.
Pharmaceuticals 17 01374 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Viveros-Paredes, J.M.; González-Castañeda, R.E.; Gertsch, J.; Chaparro-Huerta, V.; López-Roa, R.I.; Vázquez-Valls, E.; Beas-Zarate, C.; Camins-Espuny, A.; Flores-Soto, M.E. Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60. Pharmaceuticals 2024, 17, 1374. https://doi.org/10.3390/ph17101374

AMA Style

Viveros-Paredes JM, González-Castañeda RE, Gertsch J, Chaparro-Huerta V, López-Roa RI, Vázquez-Valls E, Beas-Zarate C, Camins-Espuny A, Flores-Soto ME. Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60. Pharmaceuticals. 2024; 17(10):1374. https://doi.org/10.3390/ph17101374

Chicago/Turabian Style

Viveros-Paredes, Juan M., Rocio E. González-Castañeda, Juerg Gertsch, Veronica Chaparro-Huerta, Rocio I. López-Roa, Eduardo Vázquez-Valls, Carlos Beas-Zarate, Antoni Camins-Espuny, and Mario E. Flores-Soto. 2024. "Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60" Pharmaceuticals 17, no. 10: 1374. https://doi.org/10.3390/ph17101374

APA Style

Viveros-Paredes, J. M., González-Castañeda, R. E., Gertsch, J., Chaparro-Huerta, V., López-Roa, R. I., Vázquez-Valls, E., Beas-Zarate, C., Camins-Espuny, A., & Flores-Soto, M. E. (2024). Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60. Pharmaceuticals, 17(10), 1374. https://doi.org/10.3390/ph17101374

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop